Citation: yang, b.Md, phd et al.Sixteen-year experience of david and bentall procedures in acute type a aortic dissection.Annals of thoracic surgery.(2018).Mar;105(3):779-784; doi 10.1016/j.Athoracsur.2017.09.029 earliest date of e-publish/publish used for event.No unique device identifier (serial/lot) numbers were provided; without this information, it cannot be determined whether this event has been previously reported.(b)(4).If information is provided in the future, a supplemental report will be issued.
|
Medtronic received information via literature review regarding 16 year outcomes after a david or bentall procedure to treat a type a aortic dissection.All data were collected from a single center between 2001 and 2017.The study population included 135 patients, some which were implanted with a freestyle aortic root bioprosthesis during a bentall procedure.The remaining patients were implanted with a non medtronic device.Serial numbers were not provided.The bentall study population was predominantly male; mean age 61 years.Among all patients, none of the deaths were attributed to a medtronic product.Among all patients adverse events included: cerebral vascular accident (cva), blood loss, endocarditis, atrial fibrillation (afib), myocardial infarction (mi), complete heart block (chb), structural deterioration with subsequent aortic insufficiency and reoperation.Based on the available information, these events may have been attributed to a medtronic product.However as multiple manufacturers were noted in the literature, a direct correlation could not be made between the observed adverse events and the medtronic product.No additional adverse patient effects or product performance issues were reported.
|